TruScan: How Handheld Raman Analysis Helps Intercept Fake Medicines

Overview: How TruScan’s AI-Driven Counterfeit Detection Platform Transforms Drug Safety

TruScan is a handheld, Raman-based counterfeit-detection platform in the drug-safety category that verifies the identity of pharmaceuticals and raw materials at the point of need. It addresses the bottleneck of slow, lab-dependent screening by allowing users to confirm whether a packaged product or ingredient matches an expected chemical profile without sending samples off-site.

At a high level, TruScan uses Raman spectroscopy and built-in decision algorithms to compare an unknown sample against reference libraries and return a pass or fail result. In pharmaceutical manufacturing and field inspection, this supports faster screening of incoming materials, in-process substances, and finished products, thereby reducing manual handling and shortening decision cycles. The result is a more efficient workflow for quality and operations teams, with less dependence on centralised testing for routine authenticity checks.

Last checked on 2026-08-01: TruScan remains active, continues to target pharmaceutical and biotech material verification, and now shows a next-generation RM model on the live footprint.

What is TruScan?

TruScan is a handheld Raman analyser used in drug safety workflows to verify the identity of pharmaceuticals and raw materials, including screening for counterfeit medicines. It is primarily used by pharmaceutical and biotechnology manufacturers, quality teams, and regulators that need point-of-need material verification across incoming inspection, in-process checks, and finished-product testing.

It differentiates itself through a spectroscopy-based technical approach featuring patented multivariate residual analysis and optional embedded chemometrics to support custom qualitative and quantitative methods. The live materials also include compliance statements for USP <1120> and EP <2.2.48> and describe non-destructive verification via sealed packaging, which enables faster screening without routine lab sampling.

Why Do Leading Healthcare Teams Trust TruScan?

• Thermo Fisher appears active and stable as a large public life-sciences company, which supports buyer confidence in product continuity.

• TruScan RM materials state compliance with USP <1120> and EP <2.2.48> Raman spectroscopy statements.

• The live materials identify the analyser’s laser as Class IIIb under FDA CDRH classification, indicating a defined safety classification rather than a medical device clearance.

• The product is positioned for non-destructive verification through sealed packaging, which is relevant for regulated pharmaceutical workflows.

• Embedded chemometrics and multivariate residual analysis are part of the TruScan RM technical approach.

• The catalogue page and related product pages still describe TruScan for pharmaceutical and biotechnology material identification, suggesting the product remains in use.

• Unable to source FDA clearance, CE marking, ISO certification, or HIPAA/GDPR alignment statements specific to TruScan in the live sources reviewed.

• No recent evidence that TruScan has pivoted away from healthcare or lost its functional analytical capability.